Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.

Sarcoma · 2010 · PMC2874927 · PMID 20508840

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = .06so close (0.05 < p ≤ 0.1)

Patients who responded (achieved disease control) to first-line chemotherapy were marginally more likely to respond to second-line chemotherapy though this did not reach statistical significance ( P = .06, Fishers exact test) ( Table 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.